Characteristics of metabonomics and intestinal microecology in phlegm-dampened polycystic ovary syndrom

Phase 1

Recruiting

• Conditions: Polycystic ovary syndrome

• Registration Number: ITMCTR2000003448
• Lead Sponsor: The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

1.Aged 18-40 years;
2.Body mass index > 23Kg/m3;
3.consistent with PCOS diagnosis;
4.consistent with the diagnosis of TCM syndrome differentiation.

Exclusion Criteria

1. In the past three months, people who have taken oral drugs that affect test results, such as antibiotics, birth control pills or other hormone drugs, insulin sensitizers, lipid-lowering drugs, etc.
2. Patients suffering from gastrointestinal diseases (such as diarrhea, enteritis, etc.) or diseases affecting intestinal microecology such as acute infection.
3. Patients with organic diseases of heart, lung, liver, kidney and other important organs or patients with mental disorders and other causes that cannot cooperate with the test.

Study & Design

• Study Type: Observational study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Intestinal flora;Serum metabolomics;Fasting serum insulin;Fasting glucose;

Secondary Outcome Measures

Name	Time	Method
androstenedione;Follicle-stimulating hormone;Dehydroepiandrosterone sulfate;Sex hormone binding globulin;testosterone;triglycerides;estradiol;High density lipoprotein;Low density lipoprotein;Luteinizing hormone;Total cholesterol;